Painchek Ltd · ASX:PCK
Painchek — Investor Presentation (March 2019)
22 slides from Painchek's investor presentation, Mar 12, 2019
Slide 1: Company Presentation March 2019
® For personal use only Company Presentation March 2019 PainChek Ltd ASX:PCK 1 PainChek™ Commercial in Confidence
Slide 2: Our "Why"
Our “Why” For personal use only Our purpose is to give a voice to people who cannot verbalise their pain 2 PainChek™ Commercial in Confidence
Slide 3: The PainChek Solution
The PainChek® Solution For personal use only A secure, validated, medical device in the form of a mobile app Uses existing smartphone and tablet hardware1 Artificial Intelligence (AI) technology to analyze facial expressions indicative of pain in real time 1 Edge devices (smartphones and tablets ) a
Slide 4: The PainChek App
The PainChek® App For personal use only ▪ Automated facial pain analysis: • 3 second video of a patient face • recognises 9 micro-facial expressions that indicate pain ▪ Digital questionnaire checklist: • guide the carer in other pain assessment factors e.g. movement, vocalization • leading question
Slide 5: Highlights
PainChek® Highlights Large initial global market opportunities 47M people living with dementia Proven business model For personal use only worldwide - CAGR 3% Accelerating sales in Residential Aged 400M children aged between 0-3 years Care (RAC) including Allity, Top 5 RAC old Partnering with 3rd Pa
Slide 6: Our Initial Target Markets
Our Initial Target Markets Nannies, BabysittersD ay Care Staff For personal use only Carers of non-communicative people Doctors Children, Parents & Grandparents with pain: Nurses ▪ Dementia sufferers ▪ Pre-verbal children Day Care Centres Carers of people who cannot self- GP, Outpatient, First Aid r
Slide 7: Initial Market Opportunity – Carers of People Living with Dementia
PainChek® Initial Market Opportunity – Carers of People Living with Dementia 6,000,000 7,500,000 For personal use only people living with dementia1 people living Australia with dementia1 1,200,000 carers of People with dementia3 500,000 health care professionals who could use US PainChek4 18,000,000
Slide 8: New Market Opportunity: Pre-verbal Children's App
New Market Opportunity: Pre-verbal Children’s App For personal use only • Children’s App developed with facial recognition capability • Clinical trial sites identified with major Australian children’s hospital • Trials scheduled to commence Q1/Q2 2109 • Product launch scheduled for Q4 2019 Carers ~
Slide 9: The Team
THE TEAM For personal use only Philip Daffas Prof. Jeff Hughes Mustafa Atee CEO & Managing Director, MBA, BSc Chief Scientific Officer PhD, MPS Research Scientist MPS, PhD (candidate) Philip is a highly accomplished global business Jeff is a professor in the School of Pharmacy, Mustafa is a clinical
Slide 10: The Challenge of Managing Pain for People with Dementia
The Challenge of Managing Pain for People with Dementia Pain is common For personal use only • Up to 80% of people in aged care experience chronic pain1 • More than 50% of people in Australian aged care have dementia2 • 47 Million globally living with Dementia3 growing at 3% p.a. But pain often goes
Slide 11: Evolution of Pain Assessments in Dementia
Evolution of Pain Assessments in Dementia For personal use only PainChek ® 2003 2017 • 2002 2004 AGS 11 PainChek™ Commercial in Confidence
Slide 12: Benefits Impacts All Key Stakeholders
PainChek® Benefits Impacts All Key Stakeholders For personal use only • Improve quality of life Clinical Utility • Reduce rates and severity of behavioural and psychological symptoms • Reduce rates of incorrectly prescribed antipsychotics • Point of Care testing Cost Benefit • Automated documentatio
Slide 13: App Market Entry Strategy - Australia
PainChek® App Market Entry Strategy - Australia For personal use only Residential Aged Care HCP - Enterprise Channel (RAC)* 210,000 beds 3rd Party Software Home Carers Operators Suppliers (HCO) 200,000 Packages ® Home Care 330,000 people living with dementia at home Home Carer Channel 13 PainChek™ C
Slide 14: 3rd Party Software Partners Integration Update
3rd Party Software Partners Integration For personal use only Update Australian market partners: • Health Metrics and LeeCare go live target 4/19 • New partner agreements in negotiation – targeting 6/19 • Total partner agreements will cover more than 100,000 Australian Residential Aged Care beds Ove
Slide 15: Gaining Strong Market Momentum
PainChek® Gaining Strong Market Momentum For personal use only Residential Aged Care Clients Contracted Number of Residential Aged Care Beds Clinical PainChek Assessments (Under Contract) (based on contracts signed as of month end) (Cumulative from 1 Jan 2018) 35 2,500 20000 18030 2,160 18000 30 30
Slide 16: Our Clients Include
Our Clients Include: For personal use only Partners and Supporters 16 PainChek™ Commercial in Confidence
Slide 17: Global Entry Market Strategy
PainChek® Global Entry Market Strategy Current regulatory clearance provides access for up to 40% of the global market. For personal use only 1 2 3 Australia International Expansion US entry 2020 2017/18 2019 Goal: Established sales, business model and Goal: Expand into international markets using G
Slide 18: Patent Status
PainChek® Patent Status For personal use only • Patent clearance for PCT filing received in August 2016 • National filings commenced Feb 2017 in all key global markets; • Europe • US • Australia • China • Japan 18 PainChek™ Commercial in Confidence
Slide 19: Key Milestones
PainChek® Key Milestones Dementia App Pre-Verbal Children Apps For personal use only 2018 Q4 2017 Completion of children video library, data First commercial sales achieved model and algorithm Q4 2018 Q1 2019 20 RAC Providers , 2000 beds under contract and 10,0000 Completion of Children's App for cl
Slide 20: Board
PainChek® Board • John Murray, Chair For personal use only 25 years in tech VC, multiple board roles including aged care • Philip Daffas, MD Senior global healthcare executive : Global market experience with Roche Diagnostics and Cochlear • Ross Harricks, NED Senior global medical device exec with N
Slide 21: Financial Update
PainChek® Financial Update For personal use only • Current shares on issue: 839,384,587 • Market cap undiluted at 4.2c = $35m • Unlisted Options on issue: 175,448,155 • Cash at bank: 31 December 2018: $2.3m 21 PainChek™ Commercial in Confidence
Slide 22: PainChek Ltd
® For personal use only Company Presentation March 2019 PainChek Ltd ASX:PCK 22 PainChek™ Commercial in Confidence